BridgeBio Pharma, Inc 10-Q for FY2024 Q2
BridgeBio Pharma, Inc. (BBIO)
10-Q
2024-08-01
For: 2024-06-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on August 1, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.17M
- up 32.1% from $1.64M a year earlier
- Net loss
- $75.54M
- compared with a net loss of $160.7M a year earlier
- Diluted EPS
- -$0.39
- compared with -$0.98 a year earlier